Community Health Systems In Talks to Sell Another $450M+ of Assets
CEO Tim Hingtgen says his team’s strategy to grow in key markets is working and ‘investments are yielding the intended outcomes.’
Read More
Top Vaccine Official Resigns, Citing Misinformation by RFK Jr.
RFK Jr.’s anti-vaccine beliefs lead to changes within the HHS
How does the quality of the U.S. health care system compare to other countries?
This chart collection compare health outcomes, quality of care, and access to services between the U.S. and peer countries. While inconsistent and imperfect metrics make it difficult to firmly assess system-wide health quality in the U.S., a review of the available data prior to the onset of the COVID-19 pandemic suggests that in most of…
Journalists Weigh In on Racial Trauma, Medicaid Expansion, and Opioid Settlements
KFF Health News Midwest correspondent Cara Anthony discussed healing from racial trauma on “America’s Heroes Group” on Sept. 20. Click here to watch Anthony on “America’s Heroes Group” Explore Anthony’s series on the topic, “Silence in Sikeston” KFF Health News contributor Andy Miller discussed Medicaid expansion in Georgia on WUGA’s “The Georgia Health Report” on Sept….
KFF Health Misinformation Monitor – How Abortion Misinformation Gives Rise to Restrictive Abortion Laws
This volume explores false claims suggesting abortions occur after birth, misleading narratives around the safety abortion pills, like mifepristone, and other tactics used to distort the safety of abortions. It also explores research on the acceptance of health misinformation and the proliferation of AI-generated fake news sites.
New FDA Approval Adds Chronic Kidney Disease to Ozempic’s Label
Novo Nordisk’s type 2 diabetes drug Ozempic has expanded its label to include chronic kidney disease. The new FDA approval comes as makers of GLP-1 drugs work to expand the uses of these products. The post New FDA Approval Adds Chronic Kidney Disease to Ozempic’s Label appeared first on MedCity News.
How does competition impact community health center quality of care?
That is the question posted by a recent paper by Li and Dor (2024). However, they define competition not just by the number of community health center (CHC) competitors or market concentration (e.g., Herfindahl-Hirschman Index, HHI) but also the quality of care provided by their competitors. A key methodological question is how this should be…
Forging a Noncompete Policy That Works for Healthcare
A more measured approach to noncompete clauses can be fair to physicians and provider organizations, and also serve patients better. Here are four elements for a policy on noncompetes that will work for healthcare. The post Forging a Noncompete Policy That Works for Healthcare appeared first on MedCity News.
HHS’ Proposed HIPAA Changes Are a Step in the Right Direction, But Some Providers May Struggle to Comply
HHS is proposing major changes to HIPAA for the first time in more than a decade, aiming to strengthen cybersecurity protocols for electronic health data. Healthcare cybersecurity leaders are mainly in favor of the proposal — though there are some concerns that smaller providers will struggle with the financial and operational burdens of compliance. The…
AI Can Help Better Manage Polypharmacy Patients, Study Shows
New research was published this week analyzing how AI can be used to better manage medications for senior patients who use multiple medications simultaneously. It analyzed FeelBetter’s AI platform, which pinpoints patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The post AI Can Help Better Manage Polypharmacy Patients, Study…